Tumor suppressor FBXO31 inhibits apoptosis by inactivating PARP1

被引：0
|
作者：
Choppara, S. [1 ]
Santra, M. K. [1 ]
机构：
[1] Univ Pune, Natl Ctr Cell Sci, Pune, Maharashtra, India
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P66-C004
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [1] FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma
    Huang, Hai-Li
    Zheng, Wen-Ling
    Zhao, Rui
    Zhang, Bao
    Ma, Wen-Li
    ONCOLOGY REPORTS, 2010, 24 (03) : 715 - 720
  • [2] The tumor suppressor FBXO31 preserves genomic integrity by regulating DNA replication and segregation through precise control of cyclin A levels
    Dutta, Parul
    Islam, Sehbanul
    Choppara, Srinadh
    Sengupta, Pallabi
    Kumar, Anil
    Kumar, Avinash
    Wani, Mohan R.
    Chatterjee, Subhrangsu
    Santra, Manas Kumar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (41) : 14879 - 14895
  • [3] FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex
    Kumar, R
    Neilsen, PM
    Crawford, J
    McKirdy, R
    Lee, J
    Powell, JA
    Saif, Z
    Martin, JM
    Lombaerts, M
    Cornelisse, CJ
    Cleton-Jansen, AM
    Callen, DF
    CANCER RESEARCH, 2005, 65 (24) : 11304 - 11313
  • [4] Donafenib inhibits PARP1 expression and induces DNA damage, in combination with PARP1 inhibitors promotes apoptosis in liver cancer cells
    Jiang, Jiuliang
    Yang, Pingping
    Xu, Xinyu
    Yuan, Huixiong
    Zhu, Haitao
    ANTI-CANCER DRUGS, 2024, 35 (09) : 789 - 805
  • [5] The SCFFBXO46 ubiquitin ligase complex mediates degradation of the tumor suppressor FBXO31 and thereby prevents premature cellular senescence
    Choppara, Srinadh
    Ganga, Sankaran
    Manne, Rajeshkumar
    Dutta, Parul
    Singh, Shailza
    Santra, Manas Kumar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (42) : 16291 - 16306
  • [6] LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients
    Yang Ma
    Wan-liang Sun
    Shuo Shuo Ma
    Guanru Zhao
    Zhong Liu
    Zheng Lu
    Dengyong Zhang
    BMC Bioinformatics, 24
  • [7] LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients
    Ma, Yang
    Sun, Wan-liang
    Ma, Shuo Shuo
    Zhao, Guanru
    Liu, Zhong
    Lu, Zheng
    Zhang, Dengyong
    BMC BIOINFORMATICS, 2023, 24 (01)
  • [8] FBXO31 suppresses lipogenesis and tumor progression in glioma by promoting ubiquitination and degradation of CD147
    Feng, Yan
    Liu, Mingli
    Xie, Peng
    Dong, Ruifeng
    Hao, Zhongfei
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2022, 163
  • [9] FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation
    Zou, Shuiyan
    Ma, Cunying
    Yang, Fenghua
    Xu, Xia
    Jia, Jihui
    Liu, Zhifang
    MOLECULAR CANCER RESEARCH, 2018, 16 (02) : 286 - 295
  • [10] MicroRNA-577 inhibits cardiomyocyte apoptosis induced by myocardial infarction via targeting PARP1
    Wang, Y-H.
    Zhang, X-Y.
    Han, Y-Q.
    Yan, F.
    Wu, R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (21) : 9566 - 9573
12345